| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/15/2004 | CA2490463A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | CA2489251A1 Quinazoline derivatives |
| 01/15/2004 | CA2488736A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 01/15/2004 | CA2485379A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 01/14/2004 | EP1380299A1 Remedies for vesical stimulation in association with prostatauxe |
| 01/14/2004 | EP1380296A1 Hsp inductor |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379557A2 Use of cd25 binding molecules in steroid-resistant patients |
| 01/14/2004 | EP1379528A1 Pyrazolopyrimidines as therapeutic agents |
| 01/14/2004 | EP1379524A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379519A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379516A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 01/14/2004 | EP1379507A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 01/14/2004 | EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 01/14/2004 | EP1379503A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379495A2 Ligands of the alpha-v-beta 6 integrin |
| 01/14/2004 | EP1379494A1 Fused bicyclic or tricyclic amino acids |
| 01/14/2004 | EP1379492A1 Inhibitor of monoamine uptake |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379258A1 Low salt forms of polyallylamine |
| 01/14/2004 | EP1379249A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379238A1 Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| 01/14/2004 | EP1379224A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | CN1468236A Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 01/14/2004 | CN1468232A Heterocyclic sodium/proton exchange inhibitors and method |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1466992A Medicine for treating renal failure |
| 01/14/2004 | CN1466963A Kidney relieving capsule for treating nephropathy and method for preparing the same |
| 01/14/2004 | CN1134450C LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| 01/14/2004 | CN1134442C Pyrazolopyrimidinone cGMPPDE 5 inhibitors, method for preparing the same and uses and intermediate |
| 01/14/2004 | CN1134420C Novel substituted imidazole compounds |
| 01/14/2004 | CN1134254C Transdermal therapeutic system (TTS) contg. oxybutynin |
| 01/13/2004 | US6677453 Production of polymorphic forms I and II of finasteride by complexation with group I or II metal salts |
| 01/13/2004 | US6677372 N-(3-benzofuranyl)urea-derivatives |
| 01/13/2004 | US6677368 4-aryl substituted indolinones |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677356 Concurrently administering pyridoxal-5'-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with angiotensin converting enzyme inhibitor,calcium channel blocker, adrenergic blocking agent, vasodilator or diuretic |
| 01/13/2004 | US6677355 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677351 Useful in treatment of asthma and inflammation |
| 01/13/2004 | US6677340 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | CA2172726C A1 adenosine receptor antagonists |
| 01/08/2004 | WO2004003164A2 Methods of organ regeneration |
| 01/08/2004 | WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain |
| 01/08/2004 | WO2004002978A1 Refreshment capable of stimulating movement of digestive tract |
| 01/08/2004 | WO2004002961A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002531A1 Remedies for diseases caused by vascular contraction or dilation |
| 01/08/2004 | WO2004002530A1 Remedy for chronic disease |
| 01/08/2004 | WO2004002492A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 01/08/2004 | WO2004002484A1 Phosphodiesterase inhibitor |
| 01/08/2004 | WO2004002474A1 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/08/2004 | WO2004002461A2 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2004002420A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | WO2003090665A3 Regulation of erythrocyte apoptosis |
| 01/08/2004 | WO2003087174A3 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/08/2004 | WO2003084928A8 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
| 01/08/2004 | WO2003080103A8 Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents |
| 01/08/2004 | WO2003070166A3 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
| 01/08/2004 | WO2003066205A3 Microcapsules having high carotenoid content |
| 01/08/2004 | WO2003020257A3 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| 01/08/2004 | WO2002080952A3 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | US20040006215 Human monoclonal antibodies against CD30 |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006143 Aminoalcohol derivatives |
| 01/08/2004 | US20040006134 Antiandrogenic biphenyls |
| 01/08/2004 | US20040006133 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | US20040006105 Thrombin receptor antagonists |
| 01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | US20040006057 For therapy of connective tissue disorders, inflammatory disorders, immunology/allergy disorders, infectious diseases, respiratory diseases, cardiovascular diseases, eye diseases, metabolic diseases, central nervous system (CNS) disorders |
| 01/08/2004 | US20040006032 Vaccination |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005545 Plasmid comprising heterologous viral gene sequences for diagnosis, prevention and treatment of respiratory system disorders; vaccine development; viricides |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | DE10228081A1 Verfahren zum Nachweis einer gesteigerten Tumorsuszeptibilität A method for detecting an increased tumor susceptibility |
| 01/08/2004 | DE10227269A1 Thiazolderivate Thiazole derivatives |
| 01/08/2004 | DE10224556A1 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen 1-dimethylamino-3- (3-methoxy-phenyl) 2-methyl-pentan-3-ol entaltendes drug in different formulations |
| 01/08/2004 | CA2493854A1 Phosphodiesterase inhibitor |
| 01/08/2004 | CA2493646A1 Caspase inhibitors and uses thereof |
| 01/08/2004 | CA2492066A1 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 01/08/2004 | CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist |
| 01/08/2004 | CA2491002A1 Combination of pde5 inhibitors with angiotensin ii receptor antagonists |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |